Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. (Q48491750)

12 February 2018

title

Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. (English)

1 reference

12 February 2018

author name string

Morimoto K

1

1 reference

12 February 2018

Yoshimi K

2

1 reference

12 February 2018

Tonohiro T

3

1 reference

12 February 2018

Yamada N

4

1 reference

12 February 2018

Oda T

5

1 reference

12 February 2018

Kaneko I

6

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

12 February 2018

number of pages

9

1 reference

inferred from page(s)

published in

Neuroscience

1 reference

12 February 2018

volume

84

1 reference

12 February 2018

page(s)

479-487

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Ionic dependence of glutamate neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

A potential role for apoptosis in neurodegeneration and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Quantitative histological studies on the aged human brain. II. Senile plaques and neurofibrillary tangles in senile dementia (with an appendix on their occurrence in cases of carcinoma).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Bilateral injections of beta A(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Effects of injected Alzheimer beta-amyloid cores in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Abnormalities of Glucose Metabolism in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Alzheimer's disease. Amyloid ox-tox transducers.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Therapeutic approaches related to amyloid-beta peptide and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2897%2900507-1

7 January 2021

10.1016/S0306-4522(97)00507-1

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9539218

1 reference

12 February 2018